Roivant Sciences (ROIV) Income from Continuing Operations (2020 - 2025)

Roivant Sciences' Income from Continuing Operations history spans 6 years, with the latest figure at 313701000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 50.14% year-over-year to 313701000.0; the TTM value through Dec 2025 reached 962596000.0, down 120.68%, while the annual FY2025 figure was 729764000.0, 116.05% down from the prior year.
  • Income from Continuing Operations reached 313701000.0 in Q4 2025 per ROIV's latest filing, down from 166039000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 5131180000.0 in Q4 2023 to a low of 384896000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 109349933.33, with a median of 244642000.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: tumbled 1167.12% in 2021, then soared 1433.13% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 306085000.0 in 2021, then dropped by 25.75% to 384896000.0 in 2022, then skyrocketed by 1433.13% to 5131180000.0 in 2023, then plummeted by 104.07% to 208945000.0 in 2024, then crashed by 50.14% to 313701000.0 in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Income from Continuing Operations are 313701000.0 (Q4 2025), 166039000.0 (Q3 2025), and 273911000.0 (Q2 2025).